Organon & Company focuses on improving women's health globally by offering a wide range of prescription therapies and medical devices. Its products include contraceptives like Nexplanon and NuvaRing, fertility treatments such as Follistim AQ, and treatments for postpartum bleeding like Jada. Beyond women's health, Organon also provides biosimilars for immunology and oncology, cholesterol medications, treatments for hypertension and respiratory conditions, dermatology products, bone health solutions, and non-opioid pain management options. Founded in 2020 and based in Jersey City, New Jersey, Organon serves a diverse clientele, including hospitals, pharmacies, and government agencies.
Pre-Market Stock Futures: Futures are trading mostly lower after a rather ho-hum start to the trading week on Monday. While the S&P 500 and the Nasdaq did print new highs before fading…
The Nasdaq Composite (^IXIC) is trading in the green at Friday’s open, with the index leading the major averages as legacy chipmaker Intel’s blowout earnings report reignites the AI-infrastructure trade. The Nasdaq…
